Allergan Redefines Lower Facial Aesthetic Treatment with New Protocols using Juvéderm Dermal Fillers to Sculpt and Define

The Allergan Medical Institute is running an MD Codes™ immersive digital tutorial webinar with Dr Mauricio de Maio, Plastic Surgeon, Brazil; taking place on Thursday 12 September 2019. 

This session will introduce two new MD Code™ injection trainings, the 7-point ∑hape for women and the 9-point ∑hape for men, live via the Allergan AMI Digital World. These concepts provide a treatment guideline for lower facial reshaping using established MD Codes™ injection sites to volumise the cheek as well as sculpt the chin and jawline. Dr De Maio will also introduce Juvéderm® VOLUX demonstrating how and when to use this product alongside Juvéderm® VOLUMA with lidocaine to revitalise the lower face.

The new 7-POINT SHAPE^sm for women and 9-POINT SHAPE^sm for men, a combination of JUVÉDERM® dermal filler products and treatment points for the cheek, chin and jawline. Both these innovative protocols offer facial shaping that can last for up to 18–24 months¹.

Developed in conjunction with top global plastic surgeon Dr Mauricio De Maio and using the MD Codes™ technique, these new treatment protocols can be tailored to treat patients who want to restore or create structure in the chin and jawline¹. In 2010, Dr de Maio introduced a revolutionary concept into the field of aesthetic medicine – known as the 8-point lift which he categorized as an injectable alternative to a surgical facelift. This was the first time a precise sequence and pattern of injection points was used to achieve a specific result. The success of this approach led to the development of the MD Codes^TM. Both protocols feature Juvéderm® VOLUX, a structural facial filler and the latest innovation in the JUVÉDERM® range, designed to sculpt the chin and jawline^2,3, and Juvéderm® VOLUMA (with lidocaine).

“As we age, our skin loses elasticity and volume and, with gravity pulling everything downwards, this may lead to a saggy appearance where the chin, neck and jawline begin to blend together. Using the innovative MD Codes™, together with Juvéderm^®VOLUX and Juvéderm^® VOLUMA , the 7-POINT and 9-POINT SHAPE^sm protocols can be tailored to specifically treat this problem area, with the ultimate aim of creating the lower face you want.” comments Dr Mauricio De Maio.

As part of Allergan’s ongoing commitment to excellence in medical education, these new treatment protocols are launching to medical practitioners across the globe as part of an extensive training programme, led by Dr Mauricio De Maio and run through the Allergan Medical Institute®. This training will ensure practitioners are fully prepared and ready to offer treatment-seekers this exciting new choice for lower facial shaping. For further information on training and events please visitwww.allerganmedicalinstitute.com where healthcare professionals can register. 

1. Allergan. Data on File. INT/0074/2019.Juvederm VOLUX Final Clinical Evaluation Report. Jan 2019
2. Juvéderm® VOLUX Directions for Use. 72778JR10. Revision 2018-07-26
3. Allergan. Data on File. INT/0654/2018. Juvéderm® VOLUX final clinical study report & clinical evaluation report – efficacy and duration data. Oct 2018.